Treatment of metabolic disorders using a binding protein for gastric inhibitory peptide receptor (GIPR) combined with GLP-1 agonist

摘要

Methods of treating metabolic diseases and disorders using antigen binding proteins specific for GIPR polypeptides are provided. In various embodiments, the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. In certain embodiments, the antigen binding protein is administered in combination with a GLP-1 receptor agonist.